BRM424
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BRM424, covering 2024-10-28 to 2024-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis [Phase 2]